News about Manufacturing

Nasus Pharma Partners with Aptar to Strengthen Commercialisation of Intranasal Epinephrine

Nasus Pharma Partners with Aptar to Strengthen Commercialisation of Intranasal Epinephrine

The collaboration aims to advance the clinical development and future commercialisation of NS002, Nasus Pharma’s intranasal powder epinephrine product candidate.

Manufacturing | 13/10/2025 | By Darshana 109

Sonoma Pharmaceuticals Expands Manufacturing Scope with US FDA MoCRA Registration for Microcyn-Based Facial Spray

Sonoma Pharmaceuticals Expands Manufacturing Scope with US FDA MoCRA Registration for Microcyn-Based Facial Spray

The facility was already US FDA-registered as a medical device establishment, supporting a portfolio of 510(k)-cleared products across multiple therapeutic categories.

Manufacturing | 11/10/2025 | By Darshana 130

GKB Ophthalmics Cuts Production at Goa Plant Amid Sluggish Market Demand

GKB Ophthalmics Cuts Production at Goa Plant Amid Sluggish Market Demand

GKB Ophthalmics has reduced production to 50 percent at its Tivim Industrial Estate plant in Mapusa, Goa, due to a slowdown in market demand and the complete suspension of export orders from its US subsidiary starting October 2025, following the imposition of heavy tariffs.

Manufacturing | 11/10/2025 | By Dineshwori 143

KLIFO Expands Manufacturing Capacity with New Authorised Clinical Supply Facility in Copenhagen

KLIFO Expands Manufacturing Capacity with New Authorised Clinical Supply Facility in Copenhagen

KLIFO, a leading integrated drug development and clinical supply services provider with over 30 years of expertise, has received official manufacturing and importation authorisation from the Danish Medicines Agency for its new 65,000 sq ft Abildager facility in Copenhagen.

Manufacturing | 10/10/2025 | By Darshana 149

Zydus Recalls Entecavir Batches in USA Over Impurity Concerns, Reinforces Manufacturing Quality Standards

Zydus Recalls Entecavir Batches in USA Over Impurity Concerns, Reinforces Manufacturing Quality Standards

Zydus Pharmaceuticals (USA) Inc., a subsidiary of Ahmedabad-based Zydus Lifesciences, has initiated a voluntary recall of 8,784 bottles of its liver infection treatment, Entecavir, from the U.S. market.

Manufacturing | 10/10/2025 | By Darshana 221

PharmaJet expands manufacturing portfolio with new needle-free self-injector pens for chronic diseases

PharmaJet expands manufacturing portfolio with new needle-free self-injector pens for chronic diseases

PharmaJet, a commercial-stage global leader in needle-free injection systems, has announced the expansion of its manufacturing portfolio with the development of a suite of proprietary, needle-free self-injector pens.

Manufacturing | 09/10/2025 | By Darshana 206

Lupin to Invest USD 250 Million in New USA Respiratory Drug Manufacturing Facility in Florida

Lupin to Invest USD 250 Million in New USA Respiratory Drug Manufacturing Facility in Florida

Lupin has announced plans to invest USD 250 million over the next five years to establish a new state-of-the-art manufacturing facility in Coral Springs, Florida. The facility will focus on producing over 25 essential respiratory medicines, including albuterol inhalers.

Manufacturing | 09/10/2025 | By Darshana 108

Novo Nordisk Cuts Manufacturing Jobs in USA as Global Restructuring Gains Pace

Novo Nordisk Cuts Manufacturing Jobs in USA as Global Restructuring Gains Pace

Novo Nordisk has cut production-line jobs at one of its major manufacturing sites in the USA as part of a broader global restructuring effort.

Manufacturing | 08/10/2025 | By Darshana 252

Eli Lilly to Invest Over USD 1 Billion in India to Expand Global Manufacturing and Quality Operations

Eli Lilly to Invest Over USD 1 Billion in India to Expand Global Manufacturing and Quality Operations

Eli Lilly and Company has announced plans to invest more than USD 1 billion over the next several years to expand its contract manufacturing footprint in India, aimed at enhancing global access to its innovative medicines.

Manufacturing | 07/10/2025 | By Darshana 152

PRIP Scheme to Boost Pharma MedTech R&D: Applications Open Now

PRIP Scheme to Boost Pharma MedTech R&D: Applications Open Now

The Department of Pharmaceuticals (DoP) has invited applications for the Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme.

Manufacturing | 03/10/2025 | By Dineshwori 431

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members